dc.contributor.author
Weidner, Christopher
dc.contributor.author
Wowro, Sylvia J.
dc.contributor.author
Rousseau, Morten
dc.contributor.author
Freiwald, Anja
dc.contributor.author
Kodelja, Vitam
dc.contributor.author
Abdel-Aziz, Heba
dc.contributor.author
Kelber, Olaf
dc.contributor.author
Sauer, Sascha
dc.date.accessioned
2018-06-08T04:21:23Z
dc.date.available
2015-09-22T11:45:15.090Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/17109
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-21289
dc.description.abstract
Given the significant increases in the incidence of metabolic diseases,
efficient strategies for preventing and treating of these common disorders are
urgently needed. This includes the development of phytopharmaceutical products
or functional foods to prevent or cure metabolic diseases. Plant extracts from
edible biomaterial provide a potential resource of structurally diverse
molecules that can synergistically interfere with complex disorders. In this
study we describe the safe application of ethanolic chamomile (Matricaria
recutita) flowers extract (CFE) for the treatment and prevention of type 2
diabetes and associated disorders. We show in vitro that this extract
activates in particular nuclear receptor peroxisome proliferator-activated
receptor gamma (PPARγ) and its isotypes. In a cellular context, in human
primary adipocytes CFE administration (300 µg/ml) led to specific expression
of target genes of PPARγ, whereas in human hepatocytes CFE-induced we detected
expression changes of genes that were regulated by PPARα. In vivo treatment of
insulin-resistant high-fat diet (HFD)-fed C57BL/6 mice with CFE (200 mg/kg/d)
for 6 weeks considerably reduced insulin resistance, glucose intolerance,
plasma triacylglycerol, non-esterified fatty acids (NEFA) and LDL/VLDL
cholesterol. Co-feeding of lean C57BL/6 mice a HFD with 200 mg/kg/d CFE for 20
weeks showed effective prevention of fatty liver formation and hepatic
inflammation, indicating additionally hepatoprotective effects of the extract.
Moreover, CFE treatment did not reveal side effects, which have otherwise been
associated with strong synthetic PPAR-targeting molecules, such as weight
gain, liver disorders, hemodilution or bone cell turnover. Taken together,
modulation of PPARs and other factors by chamomile flowers extract has the
potential to prevent or treat type 2 diabetes and related disorders.
en
dc.rights.uri
http://creativecommons.org/licenses/by/3.0/
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
Antidiabetic Effects of Chamomile Flowers Extract in Obese Mice through
Transcriptional Stimulation of Nutrient Sensors of the Peroxisome
Proliferator-Activated Receptor (PPAR) Family
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
PLoS ONE. - 8 (2013), 11, Artikel Nr. e80335
dcterms.bibliographicCitation.doi
10.1371/journal.pone.0080335
dcterms.bibliographicCitation.url
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0080335
refubium.affiliation
Biologie, Chemie, Pharmazie
de
refubium.mycore.fudocsId
FUDOCS_document_000000023148
refubium.note.author
Der Artikel wurde in einer Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000005424
dcterms.accessRights.openaire
open access